The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rishikesh Thakur
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rishikesh Satish Thakur, a promoter of Link Pharma Chem Ltd, disclosed acquisition of 92,808 equity shares (2.09%) through an off-market inter-se transfer between existing promoters of the company. His stake increased from 18.95% (8,41,282 shares) to 21.04% (9,34,090 shares). The transaction was executed on 30.12.2025, and the total equity capital of the company remains Rs. 4,44,05,680 divided into 44,40,568 equity shares of Rs. 10 each. No encumbrance, voting rights other than shares, or convertible instruments were involved. Since this is an inter-se transfer, the aggregate promoter group holding of the company remains unchanged.
This is an internal reshuffle within the promoter group and does not change the overall promoter ownership. Shareholders should see no material impact on stock price or control structure.